Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan C Trent

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
Cancers|July 24, 2021
Immunotherapy Strategies for Gastrointestinal Stromal TumorJunaid Arshad, Philippos A Costa, Priscila Barreto-Coelho, et al.
Rare Tumors|July 25, 2018
A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomasAndrea P Espejo, Jeremy L Ramdial, Breelyn A Wilky, et al.
Journal of Cancer Research and Clinical Oncology|November 18, 2011
PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridizationSarah N Dumont, Alexander J Lazar, Julia A Bridge, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic CancersAinhoa Madariaga, Gordon J S Rustin, Ronald J Buckanovich, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 22, 2006
Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinibXie Hong, Haesun Choi, Evelyne M Loyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Response of histiocytoses to imatinib mesylate: fire to ashesFilip Janku, Hesham M Amin, Dan Yang, et al.
Carcinogenesis|July 6, 2012
Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumorsAmaury G Dumont, Yanwen Yang, David Reynoso, et al.
JCO Precision Oncology|January 20, 2022
Utility of Circulating Tumor DNA in the Management of Patients With GI Stromal Tumor: Analysis of 243 PatientsJunaid Arshad, Ali Roberts, Jibran Ahmed, et al.
Disease Markers|February 24, 2022
IDH1 Mutation Induces HIF-1<i>α</i> and Confers Angiogenic Properties in Chondrosarcoma JJ012 CellsXiaoyu Hu, Luyuan Li, Josiane E Eid, et al.
Current Treatment Options in Oncology|May 16, 2015
Rhabdomyosarcoma in adults: new perspectives on therapyCatalina Ruiz-Mesa, John M Goldberg, Alvaro J Coronado Munoz, et al.
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
Cancers|July 24, 2021
Immunotherapy Strategies for Gastrointestinal Stromal TumorJunaid Arshad, Philippos A Costa, Priscila Barreto-Coelho, et al.
Rare Tumors|July 25, 2018
A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomasAndrea P Espejo, Jeremy L Ramdial, Breelyn A Wilky, et al.
Journal of Cancer Research and Clinical Oncology|November 18, 2011
PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridizationSarah N Dumont, Alexander J Lazar, Julia A Bridge, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic CancersAinhoa Madariaga, Gordon J S Rustin, Ronald J Buckanovich, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 22, 2006
Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinibXie Hong, Haesun Choi, Evelyne M Loyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Response of histiocytoses to imatinib mesylate: fire to ashesFilip Janku, Hesham M Amin, Dan Yang, et al.
Carcinogenesis|July 6, 2012
Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumorsAmaury G Dumont, Yanwen Yang, David Reynoso, et al.
JCO Precision Oncology|January 20, 2022
Utility of Circulating Tumor DNA in the Management of Patients With GI Stromal Tumor: Analysis of 243 PatientsJunaid Arshad, Ali Roberts, Jibran Ahmed, et al.
Disease Markers|February 24, 2022
IDH1 Mutation Induces HIF-1<i>α</i> and Confers Angiogenic Properties in Chondrosarcoma JJ012 CellsXiaoyu Hu, Luyuan Li, Josiane E Eid, et al.
Current Treatment Options in Oncology|May 16, 2015
Rhabdomyosarcoma in adults: new perspectives on therapyCatalina Ruiz-Mesa, John M Goldberg, Alvaro J Coronado Munoz, et al.
Pageof 14